• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multiple myeloma of the serosa coat.浆膜层多发性骨髓瘤。
J Cancer Res Clin Oncol. 1988;114(3):312-6. doi: 10.1007/BF00405841.
2
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.对早期预后不良或晚期霍奇金淋巴瘤患者,比较包括强化BEACOPP方案的一线化疗与包括ABVD方案的化疗。
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3.
3
The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.硼替佐米联合来那度胺与烷化剂和皮质类固醇在多发性骨髓瘤一线治疗中的临床疗效和成本效益:系统评价和经济评估。
Health Technol Assess. 2011 Dec;15(41):1-204. doi: 10.3310/hta15410.
4
Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.利妥昔单抗作为 III-IV 期滤泡性淋巴瘤的一线治疗药物(对技术评估第 110 号的回顾):一项系统评价和经济评估。
Health Technol Assess. 2012;16(37):1-253, iii-iv. doi: 10.3310/hta16370.
5
Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.联合化疗用于高危妊娠滋养细胞肿瘤的初始治疗
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD005196. doi: 10.1002/14651858.CD005196.pub4.
6
Treating newly diagnosed Diffuse Large B-cell Lymphoma in the elderly patient with R-mini-CHOP: A single centre analytical retrospective observational study.用R-mini-CHOP方案治疗老年新诊断弥漫性大B细胞淋巴瘤:一项单中心分析性回顾性观察研究。
Med J Malaysia. 2025 May;80(3):307-312.
7
A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.B 细胞慢性淋巴细胞白血病化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):224-30. doi: 10.1080/02841860151116303.
8
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.苯达莫司汀用于治疗惰性B细胞淋巴瘤患者,包括慢性淋巴细胞白血病。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009045. doi: 10.1002/14651858.CD009045.pub2.
9
Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO).与美法仑和泼尼松治疗相比,苯达莫司汀和泼尼松治疗新诊断的多发性骨髓瘤患者可产生更高的完全缓解率、延长至治疗失败的时间并改善生活质量——东德血液学和肿瘤学研究组(OSHO)的一项随机III期研究。
J Cancer Res Clin Oncol. 2006 Apr;132(4):205-12. doi: 10.1007/s00432-005-0074-4. Epub 2006 Jan 10.
10
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.初始治疗策略对晚期霍奇金淋巴瘤患者生存的影响:系统评价和网络荟萃分析。
Lancet Oncol. 2013 Sep;14(10):943-52. doi: 10.1016/S1470-2045(13)70341-3. Epub 2013 Aug 13.

引用本文的文献

1
IgG Lambda Myeloma Presenting as Plasmacytic Ascites: Case Report and Review of Literature.以浆细胞性腹水为表现的IgG λ型骨髓瘤:病例报告及文献复习
Indian J Hematol Blood Transfus. 2015 Dec;31(4):472-9. doi: 10.1007/s12288-014-0454-5. Epub 2014 Sep 3.

本文引用的文献

1
Aggressive plasma cell myeloma. A terminal phase.侵袭性浆细胞骨髓瘤。终末期。
Arch Intern Med. 1981 Sep;141(10):1315-20.
2
Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.骨髓瘤的骨髓组织学:其在诊断、预后、分类及分期中的重要性。
Br J Haematol. 1982 Jul;51(3):361-75. doi: 10.1111/j.1365-2141.1982.tb02791.x.
3
Effective treatment of advanced multiple myeloma refractory to alkylating agents.对烷化剂难治的晚期多发性骨髓瘤的有效治疗。
N Engl J Med. 1984 May 24;310(21):1353-6. doi: 10.1056/NEJM198405243102104.
4
Intracellular formation of amyloid fibrils in myeloma. Cytochemical, immunochemical, and electron microscopic observations.
Cancer. 1984 Jul 15;54(2):303-7. doi: 10.1002/1097-0142(19840715)54:2<303::aid-cncr2820540220>3.0.co;2-m.
5
Hemorrhagic ascites: an unusual complication of multiple myeloma.出血性腹水:多发性骨髓瘤的一种罕见并发症。
Calif Med. 1971 Sep;115(3):61-4.
6
Liver disease in multiple myeloma.多发性骨髓瘤中的肝脏疾病
Arch Intern Med. 1973 Aug;132(2):195-202.
7
[Extrahepatic biliary obstruction caused by infiltration of the pancreas by plasmacytoma].浆细胞瘤浸润胰腺导致的肝外胆管梗阻
Klin Wochenschr. 1985 Aug 1;63(15):718-21. doi: 10.1007/BF01733116.
8
[Treatment of multiple myeloma. Chemotherapy in primary and secondary therapeutic failure in renal failure].
Med Klin (Munich). 1987 Jan 16;82(1):16-22.
9
[Fulminating course of IgG plasmacytoma at a young age].[年轻患者IgG浆细胞瘤的暴发性病程]
Klin Wochenschr. 1986 Apr 1;64(7):348-52. doi: 10.1007/BF01711959.
10
Malignant plasmacytic ascites. A report of two cases and a review of the literature.
Cancer. 1985 Oct 15;56(8):2001-4. doi: 10.1002/1097-0142(19851015)56:8<2001::aid-cncr2820560819>3.0.co;2-9.

浆膜层多发性骨髓瘤。

Multiple myeloma of the serosa coat.

作者信息

Görg C, Adler G, Görg K, Pflüger K H, Havemann K

机构信息

Zentrum für Innere Medizin der Philipps-Universität, Abteilung Hämatologie/Onkologie/Immunologie, Marburg, Federal Republic of Germany.

出版信息

J Cancer Res Clin Oncol. 1988;114(3):312-6. doi: 10.1007/BF00405841.

DOI:10.1007/BF00405841
PMID:3384845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12243770/
Abstract

We report on a 47-year-old male patient with IgA-kappa plasmacytoma, who 12 months subsequent to diagnosis developed marked ascites. On light and electron microscopy morphologically identical plasma cells with bizarre intracytoplasmatic material were found in the bone marrow, pleural exudate, and ascites fluid. This kind of extramedullary spread is extremely rare and usually resists therapy. The mean survival rate for the 9 patients with malignant plasmacellular ascites whose cases have been documented so far was 2 months. After progression under VCMP regimens our patient has been successfully treated over a period of more than 4 years with i.v. VP16 monotherapy with additional intermittent local administration of methotrexate and systemic poly-chemotherapy according to the VAD scheme.

摘要

我们报告一例47岁的男性IgA-κ型浆细胞瘤患者,该患者在诊断后12个月出现明显腹水。在光镜和电镜下,在骨髓、胸腔渗出液和腹水中发现了形态相同且带有奇异胞浆内物质的浆细胞。这种髓外扩散极为罕见,且通常对治疗耐药。迄今为止,有文献记载的9例恶性浆细胞性腹水患者的平均生存率为2个月。在VCMP方案治疗病情进展后,我们的患者接受静脉注射VP16单药治疗,并额外间歇局部给予甲氨蝶呤,同时根据VAD方案进行全身多药化疗,成功治疗了4年多。